3,000 doses of Sputnik V arrive in Manila | Inquirer News

3,000 doses of Sputnik V arrive in Manila

By: - Reporter / @zacariansINQ
05:35 PM May 03, 2021

3,000 doses of Sputnik V arrive in Manila

Sputnik V gets distributed in Manila. PHOTO/Presidential Communications Operations Office – Office of the Global Media and Public Affairs (PCOO-OGMPA)

MANILA, Philippines — After the first batch of Sputnik V’s arrived in the country on May 1, the City of Manila received 3,000 doses from the Department of Health (DOH) on Monday.

Manila Mayor Francisco Domagoso said the city hall would prioritize frontline medical workers for the mass vaccination using the COVID-19 vaccine developed by Gamaleya Research Institute (GRI), Sputnik V.

Article continues after this advertisement

“Priority dito sa ating mga medical frontliners, ‘yung mga nasa A1 category na hindi pa nakapagpabakuna,” said Domagoso.

FEATURED STORIES

(Our priority here is our medical frontliners, those in the A1 category who have not yet been vaccinated.)

The mayor added that seniors (A2) and patients with comorbidities (A3) would get vaccinated if there are any left after those in the A1 category.

Article continues after this advertisement

The 3,000 doses of the said vaccine were allocated to the City of Manila by the Department of Health (DOH) after receiving 15,000 doses of Sputnik V, the first batch of the 20 million doses in the Philippines is eyeing to procure.

Article continues after this advertisement

READ: PH receives first batch of Sputnik V COVID-19 vaccines

Article continues after this advertisement

DOH said the first batch of Sputnik V would be distributed to four major cities in Metro Manila.

According to the Food and Drug Administration (FDA), Sputnik V has a 91.6 percent efficacy rating and is authorized to be used in 64 countries with a total population of over 3.2 billion people.

Article continues after this advertisement

The reported side effects of the said vaccine include flu-like symptoms, arm soreness, and headaches.

Sputnik V also requires two doses, much like the other vaccines currently available in the country.

Brazil, however, banned the vaccine after health regulators raised questions about its safety.

Brazil’s concerns were prompted by findings that the adenovirus used in the Sputnik V vaccine could replicate and might cause problems for those with low immunity or with respiratory complications.

Since then, Russia has said that it would sue Brazil’s health regulator for defamation.

As of May 3 at 11 a.m., the number of people who have preregistered through Manila’s registration website has reached 327,000. Out of that number, 79,561 have been vaccinated.

Meanwhile, 25,337 are already fully vaccinated or have received the second dose of their COVID-19 vaccine.

Domagoso said Manileños could register at the website: manilacovid19vaccine.ph

RELATED STORY

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

DOH not dropping Sputnik V despite Brazil rejection; 15,000 doses arrive

abc

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Manila City, Sputnik V

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.